Cellectis Inc. (CLLS) Q2 2025 Earnings Call

Investor webinar replay

Watch the replay and follow the connected company analysis, news, and investor updates for Cellectis S.a..

Watch the replay

Replay transcript excerpt

WEBVTT 00:00:00.031 -- 00:00:02.554 Please stand by, your program is about to begin. 00:00:02.554 -- 00:00:08.800 If you need assistance during the conference today, please press star zero. 00:00:08.903 -- 00:00:14.310 Good day, everyone, and welcome to today's Selectus second quarter 2025 earnings conference 00:00:14.310 -- 00:00:18.736 call. At this time, all participants are in a listen-only mode. 00:00:18.736 -- 00:00:22.221 Later, you will have the opportunity to ask questions during the question and answer 00:00:22.221 -- 00:00:27.328 session. You may register to ask a question at any time by pressing star one on your 00:00:27.328 -- 00:00:32.384 telephone keypad. you may withdraw yourself from the queue by pressing star two. 00:00:32.384 -- 00:00:37.329 Please note this call may be recorded and I'll be standing by should you need any assistance. 00:00:37.329 -- 00:00:41.933 It is now my pleasure to turn the conference over to Arthur Strill, Interim Chief Financial 00:00:41.933 -- 00:00:45.055 Officer. Please go ahead. 00:00:45.377 -- 00:00:50.702 Good morning and welcome everyone to Selectus' second quarter 2025 business 00:00:50.702 -- 00:00:54.026 update and financial results conference call. 00:00:54.026 -- 00:00:58.790 Joining me on the call today are Dr. André Choulika, our Chief Executive Officer, and 00:00:58.790 -- 00:01:02.815 Dr. Adrian Kilcoyne, our Chief Medical Officer. 00:01:02.815 -- 00:01:08.122 Yesterday evening, Selectus issued a 6K in press release reporting our financial statements 00:01:08.122 -- 00:01:12.127 for the six-month period ended June 30, 2025, 00:01:12.127 -- 00:01:17.174 and a business update. The report and press release are available on our website 00:01:17.174 -- 00:01:19.294 at selectus.com. 00:01:19.777 -- 00:01:24.774 As ...